
Rabemag 20mg Capsule
Marketer
Magma Allianz Laboratories Ltd
Salt Composition
Rabeprazole (20mg)
Overview Rabemag 20mg Capsule
Gastric acid production is reduced by the 20mg Rabemag Capsule. This medication treats stomach and intestinal conditions stemming from excess acid, including acid reflux, peptic ulcers, and Zollinger-Ellison syndrome. It offers symptom relief and aids healing. Take one Rabemag 20mg Capsule an hour before meals, ideally in the morning, as directed by your physician; dosage depends on your condition and response. Consistent daily timing is crucial, even if symptoms abate rapidly. Dietary modifications, such as smaller, more frequent meals and limiting caffeine, spicy foods, and fatty foods, may further alleviate symptoms. Common, generally mild, side effects include nausea, vomiting, headache, dizziness, gas, diarrhea, and abdominal pain; persistent or bothersome side effects require medical attention. Prolonged use (over a year) might elevate fracture risk, particularly with higher doses. Consult your doctor about bone loss prevention strategies, such as calcium and vitamin D supplementation. Hypomagnesemia (low magnesium) can occur after three months or more of use, potentially causing fatigue, confusion, dizziness, muscle spasms, and arrhythmia; your physician may monitor your magnesium levels. Rabemag 20mg Capsules are unsuitable for individuals with severe hepatic impairment, those on HIV medications, those with prior allergic reactions to similar drugs, or those with pre-existing osteoporosis. Pregnant or breastfeeding individuals should seek medical advice before use. Alcohol should be avoided due to its acid-stimulating effects. Refrain from operating machinery or vehicles if dizziness or drowsiness occurs.
Uses of Rabemag 20mg Capsule
Managing gastroesophageal reflux, peptic ulcers, and Zollinger-Ellison syndrome.
Major Benefits of Rabemag 20mg Capsule:
Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Consume Rabemag 20mg Capsules on an empty stomach.
Common Side effects of Rabemag 20mg Capsule:
- Diarrhea
- Dizziness
- Flatulence
- Headache
- Nausea
- Sore throat
- Stomach pain
- Vomiting
How to use Rabemag 20mg Capsule:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Consume the Rabemag 20mg Capsule on an empty stomach.
How Rabemag 20mg Capsule works:
Aciphex 20mg capsules, a proton pump inhibitor, lessen stomach acid production, providing relief from heartburn and acid indigestion.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Rabemag 20mg Capsules with alcohol. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Use of Rabemag 20mg Capsules during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Use of Rabemag 20mg Capsules while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking a Rabemag 20mg capsule might reduce alertness, impair vision, or cause drowsiness and dizziness. Driving should be avoided if these effects are experienced.
KidneySAFE IF PRESCRIBED
Rabemag 20mg capsules can be safely administered to individuals with renal impairment. No alteration in Rabemag 20mg capsule dosage is necessary.
LiverSAFE IF PRESCRIBED
Patients with hepatic impairment may safely use Rabemag 20mg capsules without requiring dosage modification.
What if you forget to take Rabemag 20mg Capsule :
Should you forget a Rabemag 20mg Capsule, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.
Facts to Know About Rabemag 20mg Capsule
| Label | Value |
|---|---|
| Chemical Category | Benzimidazole Sulfoxide |
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
| Behavioral Class | Gastric acid suppressants |
